Home
Library
Biological Agents
Drugs
Further Tests
Test Group
Further Test
Conditions
Signs & Symptoms
Treatments
Disorder List
Diagnosis
Standard Diagnosis
Disease List
Medication List
Diagnostic Tests
Signs & Symptoms
Contact Us
Activated Partial Thromboplastin Time (APTT)
Reference Ranges
Plasma thromboplastin antecedent
Adult ( > 16y)
20.00
TO
35.00 seconds
Conditions
Hemophilia
Plasma thromboplastin antecedent (Increased)
Von Willebrands Disease
Plasma thromboplastin antecedent (Increased)
Cirrhosis
Plasma thromboplastin antecedent (Increased)
Primary Biliary Cirrhosis
Plasma thromboplastin antecedent (Increased)
Vitamin K Deficiency
Plasma thromboplastin antecedent (Increased)
Disseminated Intravascular Coagulation
Plasma thromboplastin antecedent (Increased)
Abruptio Placentae
Plasma thromboplastin antecedent (Increased)
Dysfunctional Uterine Bleeding
Plasma thromboplastin antecedent (Increased)
Heart Transplantation
Plasma thromboplastin antecedent (Increased)
Acute Liver Failure
Plasma thromboplastin antecedent (Increased)
Alcoholic Liver Disease
Plasma thromboplastin antecedent (Increased)
Fatty Liver
Plasma thromboplastin antecedent (Increased)
Liver Cancer
Plasma thromboplastin antecedent (Increased)
Liver Fibrosis
Plasma thromboplastin antecedent (Increased)
Liver Metastases
Plasma thromboplastin antecedent (Increased)
Liver Transplantation
Plasma thromboplastin antecedent (Increased)
Liver Tumour Benign
Plasma thromboplastin antecedent (Increased)
Metastatic Liver Cancer
Plasma thromboplastin antecedent (Decreased)
Primary Liver Cancer
Plasma thromboplastin antecedent (Increased)
Acute Viral Hepatitis
Plasma thromboplastin antecedent (Increased)
Chronic Hepatitis
Plasma thromboplastin antecedent (Increased)
Congestive Hepatopathy
Plasma thromboplastin antecedent (Increased)
Fulminant Hepatitis
Plasma thromboplastin antecedent (Increased)
Hepatic Artery Occlusion
Plasma thromboplastin antecedent (Increased)
Hepatic Cysts
Plasma thromboplastin antecedent (Increased)
Hepatic Granulomas
Plasma thromboplastin antecedent (Increased)
Hepatic Ischemia
Plasma thromboplastin antecedent (Increased)
Hepatitis A
Plasma thromboplastin antecedent (Increased)
Hepatitis B Infection
Plasma thromboplastin antecedent (Increased)
Hepatitis C Infection
Plasma thromboplastin antecedent (Increased)
Hepatitis D Infection
Plasma thromboplastin antecedent (Increased)
Hepatitis E Infection
Plasma thromboplastin antecedent (Increased)
Hepatocellular Carcinoma
Plasma thromboplastin antecedent (Increased)
Hepatocellular Necrosis
Plasma thromboplastin antecedent (Increased)
Hepatoerythropoietic Porphyria
Plasma thromboplastin antecedent (Increased)
Hepatomegaly
Plasma thromboplastin antecedent (Increased)
Neonatal Hepatitis B Virus Infection
Plasma thromboplastin antecedent (Increased)
Diffuse Alveolar Hemorrhage Syndrome
Plasma thromboplastin antecedent (Decreased)
Hemorrhage Shock
Plasma thromboplastin antecedent (Decreased)
Intracerebral Hemorrhage
Plasma thromboplastin antecedent (Decreased)
Intracranial Hemorrhage
Plasma thromboplastin antecedent (Decreased)
Postpartum Hemorrhage
Plasma thromboplastin antecedent (Decreased)
Subarachnoid Hemorrhage
Plasma thromboplastin antecedent (Decreased)
Subconjunctival Hemorrhages
Plasma thromboplastin antecedent (Decreased)
Metastatic Bone Tumors
Plasma thromboplastin antecedent (Decreased)
Metastatic Breast Cancer
Plasma thromboplastin antecedent (Decreased)
Metastatic Breat Cancer
Plasma thromboplastin antecedent (Decreased)
Metastatic Renal Cancer
Metastatic Renal Cell Carcinoma
Plasma thromboplastin antecedent (Decreased)
Pancreatic Cancer
Plasma thromboplastin antecedent (Decreased)
Ovarian Cancer
Plasma thromboplastin antecedent (Decreased)
Colon Cancer
Plasma thromboplastin antecedent (Decreased)
GT:0.907